microRNA information: hsa-miR-651-5p
Section | ID | link |
---|---|---|
Mature name: | hsa-miR-651-5p | miRbase |
Accession: | MIMAT0003321 | miRbase |
Precursor name: | hsa-mir-651 | miRbase |
Precursor accession: | MI0003666 | miRbase |
Symbol: | MIR651 | HGNC |
RefSeq ID: | NR_030380 | GenBank |
Sequence: | UUUAGGAUAAGCUUGACUUUUG |
Reported expression in cancers: hsa-miR-651-5p
miRNA | cancer | regulation | reporting | PUBMED | method |
---|
Reported cancer pathway affected by hsa-miR-651-5p
miRNA | cancer | pathway | reporting | PUBMED | functional study |
---|
Reported cancer prognosis affected by hsa-miR-651-5p
miRNA | cancer | prognosis | reporting | PUBMED | functional study |
---|
Reported gene related to hsa-miR-651-5p
miRNA | cancer | gene | reporting | PUBMED |
---|---|---|---|---|
hsa-miR-651-5p | lung squamous cell cancer | FAS | "Luciferase assays showed that the FAS SNP created ......" | 23378343 |
Expression profile in cancer corhorts:
Putative target regulations
miRNA | Gene | Cancer | Interaction | Correlation beta |
---|---|---|---|---|
hsa-miR-651-5p | AFF4 | 11 cancers: BLCA; CESC; COAD; HNSC; KIRP; LUAD; LUSC; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.085; TCGA CESC -0.092; TCGA COAD -0.07; TCGA HNSC -0.128; TCGA KIRP -0.103; TCGA LUAD -0.087; TCGA LUSC -0.056; TCGA PRAD -0.112; TCGA SARC -0.076; TCGA STAD -0.061; TCGA UCEC -0.071 |
hsa-miR-651-5p | MYO1E | 9 cancers: BLCA; CESC; HNSC; KIRC; KIRP; LUAD; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.155; TCGA CESC -0.143; TCGA HNSC -0.083; TCGA KIRC -0.07; TCGA KIRP -0.1; TCGA LUAD -0.072; TCGA SARC -0.105; TCGA THCA -0.183; TCGA UCEC -0.119 |
hsa-miR-651-5p | OMD | 14 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -1.057; TCGA CESC -0.471; TCGA COAD -0.532; TCGA ESCA -0.37; TCGA HNSC -0.613; TCGA KIRC -0.597; TCGA KIRP -0.869; TCGA LUAD -0.317; TCGA LUSC -0.533; TCGA PAAD -0.424; TCGA PRAD -0.215; TCGA THCA -0.356; TCGA STAD -0.573; TCGA UCEC -0.663 |
hsa-miR-651-5p | WWTR1 | 10 cancers: BLCA; COAD; HNSC; KIRC; KIRP; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.32; TCGA COAD -0.409; TCGA HNSC -0.178; TCGA KIRC -0.147; TCGA KIRP -0.273; TCGA PAAD -0.242; TCGA PRAD -0.269; TCGA SARC -0.119; TCGA STAD -0.383; TCGA UCEC -0.139 |
hsa-miR-651-5p | SAMD4A | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUSC; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.441; TCGA CESC -0.164; TCGA COAD -0.254; TCGA ESCA -0.211; TCGA HNSC -0.134; TCGA LUSC -0.258; TCGA PRAD -0.222; TCGA SARC -0.09; TCGA THCA -0.418; TCGA STAD -0.345; TCGA UCEC -0.295 |
hsa-miR-651-5p | CPEB4 | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.22; TCGA CESC -0.253; TCGA COAD -0.118; TCGA ESCA -0.124; TCGA HNSC -0.224; TCGA KIRC -0.117; TCGA KIRP -0.184; TCGA LUAD -0.123; TCGA LUSC -0.189; TCGA PRAD -0.18; TCGA SARC -0.211; TCGA STAD -0.082; TCGA UCEC -0.164 |
hsa-miR-651-5p | BHLHE40 | 10 cancers: BLCA; CESC; COAD; HNSC; KIRP; LUAD; LUSC; PRAD; THCA; UCEC | MirTarget | TCGA BLCA -0.21; TCGA CESC -0.126; TCGA COAD -0.106; TCGA HNSC -0.088; TCGA KIRP -0.204; TCGA LUAD -0.075; TCGA LUSC -0.112; TCGA PRAD -0.279; TCGA THCA -0.331; TCGA UCEC -0.093 |
hsa-miR-651-5p | BMPR2 | 14 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.143; TCGA CESC -0.071; TCGA COAD -0.151; TCGA ESCA -0.096; TCGA HNSC -0.165; TCGA KIRC -0.184; TCGA KIRP -0.188; TCGA LUAD -0.166; TCGA LUSC -0.118; TCGA PAAD -0.118; TCGA PRAD -0.132; TCGA THCA -0.12; TCGA STAD -0.104; TCGA UCEC -0.137 |
hsa-miR-651-5p | EFHD1 | 10 cancers: BLCA; COAD; HNSC; KIRC; KIRP; LUSC; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.318; TCGA COAD -0.299; TCGA HNSC -0.18; TCGA KIRC -0.367; TCGA KIRP -0.604; TCGA LUSC -0.155; TCGA PRAD -0.309; TCGA THCA -0.164; TCGA STAD -0.358; TCGA UCEC -0.273 |
hsa-miR-651-5p | APLNR | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.333; TCGA CESC -0.225; TCGA COAD -0.249; TCGA ESCA -0.21; TCGA HNSC -0.263; TCGA KIRC -0.251; TCGA KIRP -0.755; TCGA LUAD -0.159; TCGA LUSC -0.41; TCGA THCA -0.226; TCGA STAD -0.129; TCGA UCEC -0.215 |
hsa-miR-651-5p | PMP22 | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.387; TCGA CESC -0.204; TCGA COAD -0.347; TCGA ESCA -0.288; TCGA HNSC -0.301; TCGA KIRP -0.141; TCGA LIHC -0.164; TCGA LUAD -0.199; TCGA LUSC -0.337; TCGA PRAD -0.254; TCGA THCA -0.145; TCGA STAD -0.314; TCGA UCEC -0.332 |
hsa-miR-651-5p | BIRC3 | 10 cancers: BLCA; COAD; ESCA; KIRP; LIHC; LUSC; PRAD; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.407; TCGA COAD -0.163; TCGA ESCA -0.25; TCGA KIRP -0.236; TCGA LIHC -0.277; TCGA LUSC -0.162; TCGA PRAD -0.185; TCGA SARC -0.236; TCGA THCA -0.387; TCGA UCEC -0.167 |
hsa-miR-651-5p | FMN1 | 9 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; LUSC; PRAD; SARC | MirTarget | TCGA BLCA -0.238; TCGA CESC -0.327; TCGA ESCA -0.309; TCGA HNSC -0.315; TCGA KIRC -0.228; TCGA KIRP -0.552; TCGA LUSC -0.187; TCGA PRAD -0.428; TCGA SARC -0.249 |
hsa-miR-651-5p | NEK7 | 12 cancers: BLCA; CESC; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.171; TCGA CESC -0.142; TCGA COAD -0.142; TCGA HNSC -0.09; TCGA KIRC -0.09; TCGA KIRP -0.151; TCGA LUAD -0.126; TCGA LUSC -0.152; TCGA PRAD -0.138; TCGA SARC -0.103; TCGA STAD -0.086; TCGA UCEC -0.09 |
hsa-miR-651-5p | HGF | 14 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.876; TCGA CESC -0.268; TCGA COAD -0.453; TCGA ESCA -0.29; TCGA HNSC -0.322; TCGA KIRC -0.333; TCGA KIRP -0.559; TCGA LUAD -0.278; TCGA LUSC -0.325; TCGA PAAD -0.29; TCGA PRAD -0.356; TCGA THCA -0.166; TCGA STAD -0.193; TCGA UCEC -0.299 |
hsa-miR-651-5p | MPHOSPH8 | 10 cancers: BLCA; CESC; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; SARC; UCEC | MirTarget | TCGA BLCA -0.091; TCGA CESC -0.122; TCGA HNSC -0.073; TCGA KIRC -0.084; TCGA KIRP -0.146; TCGA LUAD -0.116; TCGA LUSC -0.07; TCGA PRAD -0.129; TCGA SARC -0.064; TCGA UCEC -0.095 |
hsa-miR-651-5p | ABCG2 | 10 cancers: CESC; COAD; ESCA; KIRC; KIRP; LUAD; LUSC; PRAD; STAD; UCEC | MirTarget | TCGA CESC -0.226; TCGA COAD -0.255; TCGA ESCA -0.24; TCGA KIRC -0.196; TCGA KIRP -0.176; TCGA LUAD -0.203; TCGA LUSC -0.19; TCGA PRAD -0.294; TCGA STAD -0.257; TCGA UCEC -0.422 |
Enriched cancer pathways of putative targets